These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of two population pharmacokinetic programs, NONMEM and P-PHARM, for tacrolimus. Staatz CE, Tett SE. Eur J Clin Pharmacol; 2002 Dec; 58(9):597-605. PubMed ID: 12483452 [Abstract] [Full Text] [Related]
3. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Staatz CE, Willis C, Taylor PJ, Tett SE. Clin Pharmacol Ther; 2002 Dec; 72(6):660-9. PubMed ID: 12496747 [Abstract] [Full Text] [Related]
4. Population pharmacokinetics of tacrolimus in whole blood and plasma in asian liver transplant patients. Sam WJ, Tham LS, Holmes MJ, Aw M, Quak SH, Lee KH, Lim SG, Prabhakaran K, Chan SY, Ho PC. Clin Pharmacokinet; 2006 Dec; 45(1):59-75. PubMed ID: 16430311 [Abstract] [Full Text] [Related]
5. Covariate effects on the apparent clearance of tacrolimus in paediatric liver transplant patients undergoing conversion therapy. García Sánchez MJ, Manzanares C, Santos-Buelga D, Blázquez A, Manzanares J, Urruzuno P, Medina E. Clin Pharmacokinet; 2001 Jan; 40(1):63-71. PubMed ID: 11236810 [Abstract] [Full Text] [Related]
6. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation. Staatz CE, Willis C, Taylor PJ, Lynch SV, Tett SE. Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506 [Abstract] [Full Text] [Related]
7. Factors affecting the apparent clearance of tacrolimus in Korean adult liver transplant recipients. Lee JY, Hahn HJ, Son IJ, Suh KS, Yi NJ, Oh JM, Shin WG. Pharmacotherapy; 2006 Aug; 26(8):1069-77. PubMed ID: 16863483 [Abstract] [Full Text] [Related]
8. Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients. Sam WJ, Aw M, Quak SH, Lim SM, Charles BG, Chan SY, Ho PC. Br J Clin Pharmacol; 2000 Dec; 50(6):531-41. PubMed ID: 11136292 [Abstract] [Full Text] [Related]
13. Population pharmacokinetics of tacrolimus in adult recipients receiving living-donor liver transplantation. Fukatsu S, Yano I, Igarashi T, Hashida T, Takayanagi K, Saito H, Uemoto S, Kiuchi T, Tanaka K, Inui K, Tanaka K, Inui K. Eur J Clin Pharmacol; 2001 Sep; 57(6-7):479-84. PubMed ID: 11699612 [Abstract] [Full Text] [Related]
14. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation. Yang JW, Liao SS, Zhu LQ, Zhao Y, Zhang Y, Sun XY, Rao W, Qu W, Li WZ, Sun LY. Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550 [Abstract] [Full Text] [Related]
15. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients]. Zhang GM, Li L, Chen WQ, Bi SS, Liu X, Zhang XL, Lu W. Yao Xue Xue Bao; 2008 Jul; 43(7):695-701. PubMed ID: 18819472 [Abstract] [Full Text] [Related]
19. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients. Prytuła AA, Cransberg K, Bouts AH, van Schaik RH, de Jong H, de Wildt SN, Mathôt RA. Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785 [Abstract] [Full Text] [Related]
20. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. Guy-Viterbo V, Baudet H, Elens L, Haufroid V, Lacaille F, Girard M, Debray D, Chardot C, Reding R, Wallemacq P, Musuamba F. Pharmacogenomics; 2014 Jun; 15(9):1207-21. PubMed ID: 25141896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]